Update on Comprehensive Test Ban, & More from CRS
The Congressional Research Service has prepared an updated account of the status of the comprehensive nuclear test ban treaty (CTBT), which would prohibit explosive testing of nuclear weapons.
“As of August 2016, 183 states had signed the CTBT and 164, including Russia, had ratified it. However, entry into force requires ratification by 44 states specified in the treaty, of which 41 had signed the treaty and 36 had ratified.” The U.S. has not ratified it.
The Senate Foreign Relations Committee will hold a hearing on the CTBT tomorrow, September 7.
See Comprehensive Nuclear-Test-Ban Treaty: Background and Current Developments, September 1, 2016.
Other new and updated products from the Congressional Research Service include the following.
Climate Change: Frequently Asked Questions about the 2015 Paris Agreement, September 1, 2016
U.S. Textile Manufacturing and the Proposed Trans-Pacific Partnership Agreement, September 1, 2016
Comparing DHS Component Funding, FY2017: Fact Sheet, September 2, 2016
OPM Announces Premium Increase in the Federal Long-Term Care Insurance Program, CRS Insight, September 1, 2016
The European Union’s Small Business Act: A Different Approach, September 1, 2016
Zika Response Funding: Request and Congressional Action, updated September 1, 2016
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.